LAS101057
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 526720

CAS#: 925676-48-8

Description: LAS101057 is a Potent, Selective, and Orally Efficacious A2B Adenosine Receptor Antagonist. (last updated: 6/30/2016). LAS101057 inhibits agonist-induced IL-6 production in human fibroblasts and is active in an ovalbumin (OVA)-sensitized mouse model after oral administration, reducing airway hyperresponsiveness to methacholine, Th2 cytokine production, and OVA-specific IgE levels.


Chemical Structure

img
LAS101057
CAS# 925676-48-8

Theoretical Analysis

MedKoo Cat#: 526720
Name: LAS101057
CAS#: 925676-48-8
Chemical Formula: C18H14FN5O
Exact Mass: 335.12
Molecular Weight: 335.342
Elemental Analysis: C, 64.47; H, 4.21; F, 5.67; N, 20.88; O, 4.77

Price and Availability

Size Price Availability Quantity
25mg USD 450 2 Weeks
50mg USD 850 2 Weeks
Bulk inquiry

Synonym: LAS101057; LAS-101057; LAS 101057.

IUPAC/Chemical Name: N-(5-(3-fluoropyridin-4-yl)-6-(pyridin-3-yl)pyrazin-2-yl)cyclopropanecarboxamide

InChi Key: XUYURJQIMYCWBB-UHFFFAOYSA-N

InChi Code: InChI=1S/C18H14FN5O/c19-14-9-21-7-5-13(14)17-16(12-2-1-6-20-8-12)23-15(10-22-17)24-18(25)11-3-4-11/h1-2,5-11H,3-4H2,(H,23,24,25)

SMILES Code: O=C(C1CC1)NC2=NC(C3=CC=CN=C3)=C(C4=C(F)C=NC=C4)N=C2

Appearance: Solid powder

Purity: >95% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO, not in water

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Product Data:
Biological target: LAS101057 is a potent, selective, and orally efficacious A2B receptor antagonist.
In vitro activity: Given that the A2B receptor is known to mediate the release of the pro-inflammatory cytokine IL-6 through a mechanism dependent on the cAMP/cAMP response element binding (CREB) signaling pathway, it was decided to test the effect of 17 (LAS101057) on NECA-induced IL-6 release in human primary dermal fibroblasts as an additional means of demonstrating blockade of A2B receptor function. In this assay, 17 effected a concentration-dependent down-regulation of IL-6 production with a potency (67% ± 2 at 100 nM) that was in a similar range to that seen in both the A2B receptor radioligand binding and cAMP assays. Reference: ACS Med Chem Lett. 2010 Dec 20;2(3):213-8. https://pubmed.ncbi.nlm.nih.gov/24900298/
In vivo activity: As shown in Figure 1, 17 (LAS101057) reduced the increase of lung resistance in mice induced by methacholine. LAS101057 was active in preventing methacholine-induced AHR at 3 mg/kg, and at 10 mg/kg it inhibited AHR to methacholine to a level virtually equal to that seen with dexamethasone at 1 mg/kg. Reference: ACS Med Chem Lett. 2010 Dec 20;2(3):213-8. https://pubmed.ncbi.nlm.nih.gov/24900298/

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 125.0 372.75

Preparing Stock Solutions

The following data is based on the product molecular weight 335.34 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: 1. Eastwood P, Esteve C, González J, Fonquerna S, Aiguadé J, Carranco I, Doménech T, Aparici M, Miralpeix M, Albertí J, Córdoba M, Fernández R, Pont M, Godessart N, Prats N, Loza MI, Cadavid MI, Nueda A, Vidal B. Discovery of LAS101057: A Potent, Selective, and Orally Efficacious A2B Adenosine Receptor Antagonist. ACS Med Chem Lett. 2010 Dec 20;2(3):213-8. doi: 10.1021/ml100249e. PMID: 24900298; PMCID: PMC4018059.
In vitro protocol: 1. Eastwood P, Esteve C, González J, Fonquerna S, Aiguadé J, Carranco I, Doménech T, Aparici M, Miralpeix M, Albertí J, Córdoba M, Fernández R, Pont M, Godessart N, Prats N, Loza MI, Cadavid MI, Nueda A, Vidal B. Discovery of LAS101057: A Potent, Selective, and Orally Efficacious A2B Adenosine Receptor Antagonist. ACS Med Chem Lett. 2010 Dec 20;2(3):213-8. doi: 10.1021/ml100249e. PMID: 24900298; PMCID: PMC4018059.
In vivo protocol: 1. Eastwood P, Esteve C, González J, Fonquerna S, Aiguadé J, Carranco I, Doménech T, Aparici M, Miralpeix M, Albertí J, Córdoba M, Fernández R, Pont M, Godessart N, Prats N, Loza MI, Cadavid MI, Nueda A, Vidal B. Discovery of LAS101057: A Potent, Selective, and Orally Efficacious A2B Adenosine Receptor Antagonist. ACS Med Chem Lett. 2010 Dec 20;2(3):213-8. doi: 10.1021/ml100249e. PMID: 24900298; PMCID: PMC4018059.

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Eastwood P, Esteve C, González J, Fonquerna S, Aiguadé J, Carranco I, Doménech
T, Aparici M, Miralpeix M, Albertí J, Córdoba M, Fernández R, Pont M, Godessart
N, Prats N, Loza MI, Cadavid MI, Nueda A, Vidal B. Discovery of LAS101057: A
Potent, Selective, and Orally Efficacious A2B Adenosine Receptor Antagonist. ACS
Med Chem Lett. 2010 Dec 20;2(3):213-8. doi: 10.1021/ml100249e. eCollection 2011
Mar 10. PubMed PMID: 24900298; PubMed Central PMCID: PMC4018059.